Start TODAY members share how they stay fit for free including YouTube workouts, walking and strength training with ...
People are suddenly very concerned about the powerhouse of the cell.
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results